You are here

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

 

Online download statistics by month:

Online download statistics by month: August 2021 to October 2024

AbstractFullPdf
Aug 2021978979430
Sep 2021755757237
Oct 2021267267107
Nov 2021261261109
Dec 202116617068
Jan 2022170184104
Feb 202211912663
Mar 202218821181
Apr 202221124580
May 2022211247116
Jun 2022176204149
Jul 202214916073
Aug 202213413858
Sep 202214415579
Oct 202218119272
Nov 202217718487
Dec 202212212260
Jan 202316316467
Feb 202316716759
Mar 202316316576
Apr 202314314471
May 202311511642
Jun 202311811954
Jul 202313213249
Aug 202314014037
Sep 202310710736
Oct 202311011052
Nov 202311511547
Dec 202316416534
Jan 202412312554
Feb 202412412444
Mar 2024153156122
Apr 202414114473
May 202414114346
Jun 202411311356
Jul 202415215447
Aug 202410711148
Sep 202497971335
Oct 202411611852
Total731375314474